Search
+
    SEARCHED FOR:

    BAIN & COMPANY

    Bain Capital-backed Emcure Pharma mobilises Rs 583 cr from anchor investors

    Emcure Pharmaceuticals has allocated 57.8 lakh equity shares to 48 funds at the upper end of the IPO price band, raising Rs 582.6 crore. The public subscription for the IPO will commence on July 3rd and conclude on July 5th.

    Bain Capital-backed Emcure Pharma to float IPO on July 3

    Emcure Pharmaceuticals, backed by Bain Capital, is set to launch its IPO on July 3. The IPO includes fresh equity shares issuance and Offer of Sale. Proceeds will be used for debt payment and corporate purposes.

    Herd on PE Street: TPG outruns everyone in race for Altimetrik

    Last month, its Asia-focused fund TPG Asia VIII secured $5.3 billion in aggregate capital commitments. That made it the firm’s largest Asia fund in 30 years of investing in the region. Since inception, TPG Asia has ploughed more than $13 billion into core sectors including consumer, healthcare, financial services and TMT/new economy and the fund has realised more than $16 billion, according to its website.

    Morgan Stanley buys 3.13 crore shares of L&T Finance for Rs 534 crore via block deal

    Bain Capital sold 8.82 crore shares of the company through its affiliates BC Asia Investment VI and BC Asia Growth Investment. For sometime, it has been planning a complete exit from L&T Finance by selling its existing stake.

    L&T Finance shares surge 5% after Bain Capital dilutes stake via block deal

    L&T Finance shares surged 5% to an all-time high of Rs 179 as Bain Capital sold 8.82 crore shares in a block deal. The private equity giant, aiming for a complete exit, divested its 3.5% stake through affiliates BC Asia Investment VI and BC Asia Growth Investment.

    Bain Capital and BNP Paribas to sell L&T Finance shares worth Rs 1,500 crore

    The block deal is estimated at a discount of 1% to the current market price of the shares and BNP Paribas could be the broker to the deal. Two entities of Bain Capital — BC Asia Growth Investments and BC Investments VI — along with BNP Paribas Financial Markets will together sell a 3.54% stake on Thursday.

    The Economic Times
    BACK TO TOP